Abstract |
Two cases of intractable overactive bladder which were treated by intradetrusor botulinum-A toxin (BTX-A) are presented. Case 1: A 53-year-old woman suffered from adhesive arachinoiditis. She had severe detrusor hyperreflexia and urge urinary incontinence despite a high dose of anticholinergic medication. Under cystoscopic control, a total of 300 units of BTX-A were injected into the detrusor muscle at 30 sites (10 units per ml per site), sparing the trigone area using a 27G flexible injection needle. This procedure was done under both caudal anesthesia with 10 ml 1% lidocaine and bladder mucosa anesthesia by instilling 40 ml 2% lidocaine. At a 12-week followup she was completely continent. Case 2: A 63-year-old man with intractable detrusor overactivity of idiopathic origin was treated using the above technique. Urge urinary incontinence decreased 4 weeks after the BTX-A injections. However, postvoid residual urine volume was increased, and intermittent self-catheterization was needed. Intradetrusor BTX-A dramatically increases the bladder capacity and decreases the frequency of urge urinary incontinence. However, this treatment caused urinary retention in Case 2. We believe that the dosage amount of BTX-A should be changed case by case.
|
Authors | Takeshi Watanabe, Motoaki Saito, Shinji Hirakawa, Ikuo Miyagawa |
Journal | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
(Nihon Hinyokika Gakkai Zasshi)
Vol. 96
Issue 4
Pg. 511-4
(May 2005)
ISSN: 0021-5287 [Print] Japan |
PMID | 15948413
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Botulinum Toxins, Type A
(therapeutic use)
- Female
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Urinary Bladder
- Urinary Incontinence
(drug therapy)
|